Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Harriette Van Spall , Steven E Nissen Added: 1 year ago
ACC.23/WCC — Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by principal investigator, Dr Steven Nissen (Cleveland Clinic, Cleveland, OH, US) to have a deep dive into the practice-changing CLEAR-Outcomes trial (NCT02993406).The Phase 3 CLEAR-Outcomes trial was conducted to evaluate the impact of bempedoic acid (ETC-1002) on the occurrence of major cardiovascular… View more
Job title: Associate Professor
Dr Stephen D Wiviott is senior investigator and chairman of the Clinical Events Committee with the Thrombolysis in Myocardial Infarction (TIMI) Study Group. In addition, he is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and an associate professor of medicine at Harvard Medical School (HMS). Dr Wiviott’s research focuses on platelet function and antiplatelet… View more
Job title: Associate Professor of Medicine, and Cardiovascular Medicine Director, Cardiovascular Fellowship Program
Author(s): Purvi Parwani Added: 1 year ago
AHA 23 — Dr Purvi Parwani, cardiologist and multimodality imager, and director of the Women's Heart Clinic at Loma Linda University Health in the US, spotlights three game-changing late-breaking science trials from the AHA Scientific Sessions. Discover the trials anticipated to reshape clinical practices as Dr Parwani shares her insights.Trials discussed in detail include:POP-HT: Cardiac… View more
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 5 months ago
ESC Congress 24 – Day 4 of the ESC Congress 2024 was filled with hot line and late-breaking data poised to influence cardiovascular practice.Interventional experts DrMirvat Alasnagand DrKhaled Al-Shaibi(King Fahd Armed Forces Hospital, SA) joined us to review and distil the key messages from the latest data presented at the last of the biggest cardiovascular event of 2024.Day 4 Highlights:00:19… View more
Author(s): Enoch Akowuah , Annapoorna Kini , Atul Verma , et al Added: 1 year ago
Our regular review series View from the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen(Thoraxcentre, Erasmus MC, Rotterdam, NL) provides a critical analysis of the late-breaking and featured science results and spotlights impactful data. For a deeper look into the key clinical trial data revealed at ACC 23, Dr Harriette Van Spall(McMaster University, Hamilton, CA)… View more
Author(s): Harriette Van Spall , Stefan James Added: 6 months ago
What's hot at the ESC Congress 2024?Stay ahead of the curve with our faculty-led coverage of the European Society of Cardiology Congress in London. From groundbreaking trials to expert insights, we've got you covered.Watch ourView From the Thoraxcenterseries for practice-focused reviews of the most anticipated trials from interventional experts,Prof Nicolas Van MieghemandDr Joost Daemen.For a… View more
Added: 1 year ago Source:  AHA, Jordan Rance
The American Heart Association has announced eight late-breaking science sessions to be presented in Philadelphia from November 10th to November 13th. AHA is focussed on innovation in cardiovascular disease for scientists, clinicians, researchers and other healthcare professionals. Among the event’s highlights are eight late-breaking trial sessions, as listed below. Watch our coverage of… View more